Needle-Free Injection System Market Scope, Growth, Size and Share by 2028
Needle-Free Injection System Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 131.64 Million |
Market Size by 2028 | US$ 411.31 Million |
Global CAGR (2021 - 2028) | 17.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Industry Developments and Future Opportunities:
Various initiatives taken by major players operating in the global needle-free injection system market are listed below:
- In November 2023, Micron Biomedical received funds to manufacture needle-free vaccines. The vaccine is painless to administer and works by applying the microarray technology to the skin and pressing a button for delivery.
- In June 2022, NovaXS launched its patented ‘Telosis technology’ to administer a narrow stream of medication without a needle in 0.3 seconds for smarter health decisions.
- In December 2022, Prejex Inc. announced an agreement with Polybond to manufacture needleless injections.
- In November 2020, PharmaJet, a leading manufacturer of needle-free injection devices, announced a strategic partnership with Mundipharma, a global pharmaceutical company. This partnership aimed to expand the availability of PharmaJet's needle-free injection technology for administering vaccines and medications.
Competitive Landscape and Key Companies:
PharmaJet, Portal Instruments, Medical International Technology, Inc., NuGen Medical Devices, Crossject SA, Antares Pharma, 3M, Injex Pharma AG, NovaXS Biotech, INVIO Pharmaceutical Inc. are the major needle-free injection system companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.